Your browser doesn't support javascript.
loading
A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt.
Elezbawy, Baher; Fasseeh, Ahmad Nader; Sedrak, Amal; Eldessouki, Randa; Gamal, Mary; Eldebeiky, Mariam; Amer, Hanaa; Akeel, Shimaa; Morsy, Ahmad; Amin, Amira; Shafik, Amr; Abaza, Sherif; Kaló, Zoltán.
Afiliação
  • Elezbawy B; Syreon Middle East, Alexandria, Egypt. baher.elezbawy@gmail.com.
  • Fasseeh AN; Syreon Middle East, Alexandria, Egypt.
  • Sedrak A; Eötvös Loránd University, Budapest, Hungary.
  • Eldessouki R; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt.
  • Gamal M; Fayoum University, Fayoum, Egypt.
  • Eldebeiky M; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt.
  • Amer H; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt.
  • Akeel S; Ain Shams University, Cairo, Egypt.
  • Morsy A; The Egyptian Authority for Unified Procurement, Medical Supply, and The Management of Medical Technology (UPA), Cairo, Egypt.
  • Amin A; Presidential Program for Women's Health, Ministry of Health and Population (MoHP, Cairo, Egypt.
  • Shafik A; Egyptian Pharmaceutical Vigilance Center, Egyptian Drug Authority (EDA), Cairo, Egypt.
  • Abaza S; Ain Shams University, Cairo, Egypt.
  • Kaló Z; Syreon Middle East, Cairo, Egypt.
J Pharm Policy Pract ; 15(1): 10, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-35232487
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: J Pharm Policy Pract Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies Idioma: En Revista: J Pharm Policy Pract Ano de publicação: 2022 Tipo de documento: Article